CenterBook Partners LP trimmed its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 78.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,473 shares of the company's stock after selling 76,422 shares during the quarter. CenterBook Partners LP owned 0.14% of U.S. Physical Therapy worth $1,755,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently added to or reduced their stakes in the stock. Legal & General Group Plc bought a new position in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $2,339,000. Bank of New York Mellon Corp acquired a new stake in U.S. Physical Therapy in the 2nd quarter valued at $9,087,000. Renaissance Technologies LLC grew its position in U.S. Physical Therapy by 23.4% in the first quarter. Renaissance Technologies LLC now owns 76,956 shares of the company's stock valued at $5,769,000 after acquiring an additional 14,582 shares during the period. BlackRock Inc. bought a new stake in U.S. Physical Therapy in the second quarter valued at $155,505,000. Finally, Royal Bank of Canada grew its position in U.S. Physical Therapy by 22.0% in the first quarter. Royal Bank of Canada now owns 133,777 shares of the company's stock valued at $10,029,000 after acquiring an additional 24,081 shares during the period.
Trending Headlines about U.S. Physical Therapy
Here are the key news stories impacting U.S. Physical Therapy this week:
U.S. Physical Therapy Trading Up 0.5%
USPH stock opened at $100.02 on Monday. The business has a fifty day moving average price of $84.20 and a 200 day moving average price of $77.04. U.S. Physical Therapy, Inc. has a fifty-two week low of $58.19 and a fifty-two week high of $101.18. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of -74.09, a P/E/G ratio of 2.74 and a beta of 1.16. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.42 and a quick ratio of 1.42.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.76 by $0.04. The company had revenue of $222.56 million for the quarter, compared to analyst estimates of $214.48 million. U.S. Physical Therapy had a return on equity of 10.19% and a net margin of 3.60%. The business's revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.66 earnings per share. Analysts expect that U.S. Physical Therapy, Inc. will post 2.87 EPS for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, December 11th. Investors of record on Monday, November 16th will be given a dividend of $0.46 per share. The ex-dividend date is Monday, November 16th. This represents a $1.84 annualized dividend and a yield of 1.8%. U.S. Physical Therapy's dividend payout ratio is -136.30%.
Analysts Set New Price Targets
Several research analysts have issued reports on the company. JPMorgan Chase & Co. increased their price objective on U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an "overweight" rating in a research note on Friday, September 11th. Weiss Ratings restated a "hold (c-)" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. Citigroup reaffirmed a "market outperform" rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. Finally, Barrington Research increased their target price on shares of U.S. Physical Therapy from $98.00 to $110.00 and gave the stock an "outperform" rating in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $101.25.
View Our Latest Research Report on U.S. Physical Therapy
U.S. Physical Therapy Profile
(
Free Report)
U.S. Physical Therapy, Inc NYSE: USPH operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.
In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.